Neurobiological Technologies, Inc.
NTII · OTC
9/30/2009 | 6/30/2009 | 3/31/2009 | 12/31/2008 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $9,583 | $8,230 | $6,009 | $6,914 |
| Short-Term Investments | $16,906 | $15,819 | $15,592 | $16,400 |
| Receivables | $3,000 | $184 | $229 | $200 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $0 | $0 | $0 |
| Total Curr. Assets | $29,694 | $24,538 | $21,924 | $23,791 |
| Property Plant & Equip (Net) | $36 | $70 | $106 | $132 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $7,202 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $52 | $52 | $85 | $8,961 |
| Total NC Assets | $88 | $122 | $7,393 | $9,093 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $29,782 | $24,660 | $29,317 | $32,884 |
| Liabilities | – | – | – | – |
| Payables | $0 | $21 | $385 | $366 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $96 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $5,500 | $5,500 |
| Other Curr. Liab. | $29 | $295 | $233 | $0 |
| Total Curr. Liab. | $655 | $1,115 | $12,102 | $14,032 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $9,167 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $10,542 |
| Total NC Liab. | $0 | $0 | $9,167 | $10,542 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $655 | $1,115 | $21,269 | $24,574 |
| Equity | – | – | – | – |
| Pref Stock | $247 | $247 | $247 | $247 |
| Common Stock | $27 | $27 | $27 | $27 |
| Retained Earnings | -$117,063 | -$122,468 | -$136,622 | -$136,192 |
| AOCI | $70 | $0 | -$1,312 | -$1,360 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $29,127 | $23,545 | $8,048 | $8,310 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $29,782 | $24,660 | $29,317 | $32,884 |
| Net Debt | -$9,583 | -$8,230 | -$6,009 | -$6,914 |